4Cooper N, Stasi R, Cunningham-Rundles S, et al.Platelet- associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia[J].Br J Haematol, 2012, 158(4): 539-547.
5Robak T, Windyga J, Trelinski J, et al.Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia[J].Blood, 2012, 120(18): 3670-3676.